STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Clinical trials for STAGE IV PANCREATIC CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PANCREATIC CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IV PANCREATIC CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo enters early trial for Tough-to-Treat digestive cancers
Disease control OngoingThis early-stage study is testing a combination of two drugs, guadecitabine and durvalumab, in people with advanced cancers of the liver, pancreas, bile duct, or gallbladder that have spread. The main goals are to find the safest dose and see what side effects occur. Researchers …
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Early trial tests unusual combo against tough pancreatic cancer
Disease control OngoingThis early-stage study is testing the safety and feasibility of combining standard chemotherapy drugs with a diabetes medication (metformin) and a specific blend of dietary supplements in patients with advanced pancreatic cancer that cannot be surgically removed. The goal is to s…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test new drug cocktail in fight against tough pancreatic cancers
Disease control OngoingThis early-stage study is testing the safety and best doses of a combination of two or three drugs (vismodegib, erlotinib, and sometimes gemcitabine) in people with advanced pancreatic cancer or other solid tumors that cannot be removed by surgery. The goal is to see if blocking …
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill aims to supercharge radiation against tough cancers
Disease control OngoingThis early-stage study is testing a new oral drug called ropidoxuridine (IPdR) in patients with advanced gastrointestinal cancers that have spread. The main goal is to find the safest dose of the drug when taken daily alongside standard radiation therapy. Researchers hope the dru…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Scientists test new drug duo to starve and stop advanced cancers
Disease control OngoingThis study is testing whether taking two oral drugs, cediranib and olaparib, together can help control advanced cancers that have spread or cannot be surgically removed. It is for adults with specific types of advanced lung, breast, or pancreatic cancer who have already tried at …
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New hope for tough pancreatic cancers: adding a targeted drug to chemo
Disease control OngoingThis study is for people whose pancreatic cancer has spread and worsened after their first treatment. It compares a standard chemotherapy (FOLFIRI) against the same chemo plus an experimental drug called veliparib. The goal is to see if the combination helps patients live longer …
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Scientists test new drug cocktail in fight against tough pancreatic cancer
Disease control OngoingThis early-stage study is testing a combination of three drugs (gemcitabine, dasatinib, and erlotinib) in patients with advanced pancreatic cancer that has spread or cannot be surgically removed. The main goals are to find the safest and most effective dose and to understand the …
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Custom cancer vaccine tailored from Patient's own tumor tested in new trial
Disease control OngoingThis early-stage study is testing a personalized vaccine made from a patient's own tumor cells and blood. It aims to see if creating and giving this custom vaccine is safe and possible for people with advanced pancreatic or colorectal cancer that has spread. The vaccine is design…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
First-in-Human trial tests direct tumor injection to fight deadly pancreatic cancer
Disease control OngoingThis early-stage study is testing a new vaccine therapy for people with advanced pancreatic cancer that cannot be removed by surgery. The goal is to find a safe dose and see if injecting the vaccine directly into the tumor, along with an immune-boosting drug, can help the body's …
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC